[1]孙 立,徐大志,杨 春,等.基于数据挖掘研究严光俊治疗胃癌用药规律[J].医学信息,2024,37(10):6-10.[doi:10.3969/j.issn.1006-1959.2024.10.002]
　SUN Li,XU Da-zhi,YANG Chun,et al.Study on the Medication Rule of YAN Guang-jun in the Treatment of Gastric Cancer Based on Data Mining[J].Journal of Medical Information,2024,37(10):6-10.[doi:10.3969/j.issn.1006-1959.2024.10.002]
点击复制

基于数据挖掘研究严光俊治疗胃癌用药规律()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
37卷
期数:
2024年10期
页码:
6-10
栏目:
中医药信息学
出版日期:
2024-05-15

文章信息/Info

Title:
Study on the Medication Rule of YAN Guang-jun in the Treatment of Gastric Cancer Based on Data Mining
文章编号:
1006-1959（2024）10-0006-05
作者:
孙 立; 徐大志; 杨 春; 等
（1.广水市第一人民医院肾病血液内科，湖北 广水 432700；2.荆州市中医医院肿瘤科，湖北 荆州 434000；3.荆州市中医医院妇科，湖北 荆州 434000）
Author(s):
SUN Li; XU Da-zhi; YANG Chun; et al.
(1.Department of Nephrology and Hematology,No.1 People’s Hospital of Guangshui,Guangshui 432700,Hubei,China;2.Department of Oncology,Jingzhou Hospital of Traditional Chinese Medicine,Jingzhou 434000,Hubei,China;3.Department of Gynecology,Jingzhou Hospital of Traditional Chinese Medicine,Jingzhou 434000,Hubei,China)
关键词:
胃癌; 用药规律; 数据挖掘; 名医经验
Keywords:
Gastric cancer; Medication rule; Data mining; Experience of famous doctors
分类号:
R273
DOI:
10.3969/j.issn.1006-1959.2024.10.002
文献标志码:
A
摘要:
目的 总结严光俊教授治疗胃癌的用药规律。方法 收集严光俊教授治疗胃癌医案120例，符合纳入标准的病案资料录入“古今医案云平台（V2.3.5版本）”，运用“数据挖掘”模块中的统计分析、关联分析等分析方法，总结严光俊教授治疗胃癌的用药特色、应用规律和经验。结果 120例医案用药共164种，以补气、健脾、祛湿、化痰、清热解毒、滋阴、温阳、行气、活血化瘀类药物为主。治法按频率排序依次为：补气通痞化积法＞扶阳通痞化积法＞清热通痞化积法＞养阴通痞化积法＞祛痰通痞化积法＞活血通痞化积法＞解毒通痞化积法。对排序前3的治法进行药物关联分析，置信度设为0.9,支持度设为0.5，补气通痞化积法得到关联规则药物7条，扶阳通痞化积法关联规则药物19条，清热通痞化积法关联药物16条。结论 严光俊教授治疗胃癌的治疗以养脾胃、扶正固本，注重通降、调气机，抗癌解毒贯穿始终为治疗原则，为胃癌临床用药提供指导。
Abstract:
Objective To summarize the medication rules of Professor YAN Guang-jun in the treatment of gastric cancer.Methods The medical records of 120 cases of gastric cancer treated by Professor YAN Guang-jun were collected, and the medical records that met the inclusion criteria were entered into the "Ancient and Modern Medical Records Cloud Platform (Version 2.3.5)". The statistical analysis, correlation analysis and other analysis methods in the data mining module were used to summarize the medication characteristics, application rules and experience of Professor YAN Guang-jun in the treatment of gastric cancer.Results A total of 164 kinds of drugs were used in 120 medical cases, mainly for tonifying qi, invigorating spleen, dispelling dampness, resolving phlegm, clearing heat and detoxifying, nourishing yin, warming yang, promoting qi, promoting blood circulation and removing blood stasis. The order of treatment according to frequency was: Buqi Tongpi Huaji method>Fuyang Tongpi Huaji method>Qingre Tongpi Huaji method>Yangyin Tongpi Huaji method>Qutan Tongpi Huaji method>Huoxue Tongpi Huaji method>Jiedu Tongpi Huaji method. The drug association analysis was performed on the top 3 treatment methods, the confidence level was set to 0.9, and the support level was set to 0.5, there were 7 association rule drugs were obtained by Buqi Tongpi Huaji method, 19 association rule drugs were obtained by Fuyang Tongpi Huaji method, and 16 association drugs were obtained by Qingre Tongpi Huaji method.Conclusion Professor YAN Guang-jun in the treatment of gastric cancer is based on the principle of nourishing the spleen and stomach, strengthening the body, paying attention to the descending and regulating qi, and anti-cancer and detoxification throughout the treatment, so as to provide guidance for clinical medication of gastric cancer.

参考文献/References:

[1]国家卫生健康委员会.胃癌诊疗规范(2018年版)[J].中华消化病与影像杂志(电子版),2019,9(3):118-144．[2]王少明,郑荣寿,张思维,等.2015年中国胃癌流行特征分析[J].中华流行病学杂志,2019,40(12):1517-1521.[3]李星,樊巧玲.胃癌中医辨证与方药应用的文献研究[J].中医杂志,2017,58(8):693-696.[4]张乙,杨琳蔚,李杰,等.基于核心病机的胃癌辨病治疗[J].中华中医药杂志,2020,35(1):300-303.[5]林翔英,林翠丽,田琳,等.脾胃湿热与胃癌前病变炎-癌转化机制的关系简析[J].中医杂志,2021,62(17):1473-1477.[6]吴含秋,沈克平.中医扶正法在胃癌防治中的应用[J].上海中医药大学学报,2022,36(4):92-97.[7]郭群,陈子瑶,邓鑫,等.胃癌从气血论治[J].辽宁中医杂志,2019,46(11):2303-2305.[8]蒲香蓉,冯宇,王茂云,等.人参养荣汤在恶性肿瘤治疗中的运用及研究[J].吉林中医药,2017,37(5):505-508.[9]刘梓燊,杨国旺.基于网络药理学分析“黄芪-白术”治疗肺癌的作用机制[J].中山大学学报(自然科学版),2020,59(5):134-143.[10]郭晨旭,刘静波,赵艳,等.白术抑制胃癌细胞SGC-7901增殖并促进其凋亡[J].中国组织化学与细胞化学杂志,2017,26(5):468-474.[11]孔祥军,岳小强.论“阴虚痰凝毒结”是晚期胃癌的核心病机[J].中医药导报,2017,23(14):56-58.[12]朱广辉,李杰.基于“阳非有余”及“阳常有余”探讨温阳法论治恶性肿瘤[J].辽宁中医药大学学报,2021,23(12):41-44.[13]朱鹏程,罗毅.基于“阳化气,阴成形”及伏阳学说的肿瘤病机刍议[J].南京中医药大学学报,2022,38(3):187-192.[14]窦建卫,杨小娟,李康乐,等.从气机升降探讨胃癌的病机治则[J].辽宁中医杂志,2020,47(2):76-77.[15]张林超.白花蛇舌草多糖对肾癌荷瘤小鼠肿瘤生长及免疫调节作用的影响[J].中成药,2021,43(3):765-769.[16]修朋程,李腾,李雅林,等.泰山山慈菇对小鼠肝癌的治疗作用及相关免疫机制研究[J].医学信息,2018,31(9):8-11.[17]阮祥美,余莹,胡玲.“半枝莲－白花蛇舌草”药对治疗胃癌的网络药理学作用机制分析[J].中华中医药学刊,2020,38(11):176-180.[18]尹慧萍,王兵兵,黄泽月,等.壁虎粗多肽对SH-SY5Y细胞增殖和凋亡的影响[J].中国临床药理学杂志,2021,37(6):681-684.[19]王倩,周改莲,周文良,等.蜂房的研究进展及其质量标志物预测分析[J].中华中医药学刊,2021,39(1):254-258.

相似文献/References:

[1]尹晓华,刘重元,黄 琳,等.胃癌中lncRNAs的研究进展[J].医学信息,2018,31(03):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
　YIN Xiao-hua,LIU Zhong-yuan,HUANG Lin,et al.Research Progress of lncRNAs in Gastric Cancer[J].Journal of Medical Information,2018,31(10):10.[doi:10.3969/j.issn.1006-1959.2018.03.004]
[2]芮昆昆,章 波,邰小华,等.基质金属蛋白酶2与蛋白磷酸酶2A的癌性抑制因子在胃癌中的研究进展[J].医学信息,2018,31(03):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
　RUI Kun-kun,ZHANG Bo,TAI Xiao-hua,et al.The Research Progress of Matrix Metalloproteinase 2 and Cancer Inhibitor of Protein Phosphatase 2A in Gastric Cancer[J].Journal of Medical Information,2018,31(10):21.[doi:10.3969/j.issn.1006-1959.2018.03.007]
[3]段 巍.1例晚期胃癌化疗并发嗜血细胞综合征患者的护理[J].医学信息,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
　DUAN Wei.Nursing Care of a Case of Advanced Gastric Carcinoma with Hemophagocytic Syndrome after Chemotherapy[J].Journal of Medical Information,2018,31(10):181.[doi:10.3969/j.issn.1006-1959.2018.10.063]
[4]潘理会,李育庄,李春辉.胃癌与高凝血状态关系的研究现状[J].医学信息,2018,31(11):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
　PAN Li-hui,LI Yu-zhuang,LI Chun-hui.Research Status of the Relationship between Gastric Carcinoma and Hypercoagulable State[J].Journal of Medical Information,2018,31(10):15.[doi:10.3969/j.issn.1006-1959.2018.11.005]
[5]李虹霞,刘伏山.慢性萎缩性胃炎的中西医治疗[J].医学信息,2022,35(11):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
　LI Hong-Xia,LIU Fu-shan.Treatment of Chronic Atrophic Gastritis with Traditional Chinese and Western Medicine[J].Journal of Medical Information,2022,35(10):29.[doi:10.3969/j.issn.1006-1959.2022.11.009]
[6]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
　LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(10):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[7]林跃韩,许庆文.腹腔镜uncut Roux-en-Y吻合与传统吻合方式的研究进展[J].医学信息,2018,31(22):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
　LIN Yue-han,XU Qing-wen.Research Progress of Laparoscopic uncut Roux-en-Y Anastomosis and Traditional Anastomosis[J].Journal of Medical Information,2018,31(10):31.[doi:10.3969/j.Ⅰssn.1006-1959.2018.22.010]
[8]马玉涛,石文娜,李晓林,等.免疫荧光法检测FSHR与GnRHR在胃癌组织中的分布及其共定位研究[J].医学信息,2018,31(23):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
　MA Yu-tao,SHI Wen-na,LI Xiao-lin,et al.Study on the Distribution and Co-localization of FSHR and GnRHR in Gastric Cancer Tissues by Immunofluorescence Assay[J].Journal of Medical Information,2018,31(10):79.[doi:10.3969/j.issn.1006-1959.2018.23.022C]
[9]赵 静.血浆纤维蛋白原和CA724水平在胃癌患者的变化及临床意义[J].医学信息,2018,31(24):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
　ZHAO Jing.Changes and Clinical Significance of Plasma Fibrinogen and CA724 Levels in Patients with Gastric Cancer[J].Journal of Medical Information,2018,31(10):82.[doi:10.3969/j.issn.1006-1959.2018.24.021]
[10]万 芳.以贫血为首发症状的消化道恶性肿瘤临床分析[J].医学信息,2018,31(24):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]
　WAN Fang.Clinical Analysis of Digestive Tract Malignancies with Anemia as the First Symptom[J].Journal of Medical Information,2018,31(10):175.[doi:10.3969/j.issn.1006-1959.2018.24.054]

更新日期/Last Update: 1900-01-01